AthenaHealth (ATHN) Is Today's Dead Cat Bounce Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified AthenaHealth ( ATHN) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified AthenaHealth as such a stock due to the following factors:

  • ATHN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $88.5 million.
  • ATHN has traded 546,270 shares today.
  • ATHN is up 3% today.
  • ATHN was down 7.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ATHN with the Ticky from Trade-Ideas. See the FREE profile for ATHN NOW at Trade-Ideas

More details on ATHN:

athenahealth, Inc., together with its subsidiaries, operates as a business services company that provides ongoing billing, clinical-related, and other related services to medical group practices and health systems in the United States. Currently there are 13 analysts that rate AthenaHealth a buy, 1 analyst rates it a sell, and 9 rate it a hold.

The average volume for AthenaHealth has been 474,700 shares per day over the past 30 days. AthenaHealth has a market cap of $4.7 billion and is part of the technology sector and computer software & services industry. The stock has a beta of 1.89 and a short float of 40.8% with 14.14 days to cover. Shares are down 22% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com Analysis:

TheStreet Quant Ratings rates AthenaHealth as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself.

Highlights from the ratings report include:
  • ATHN's revenue growth has slightly outpaced the industry average of 21.9%. Since the same quarter one year prior, revenues rose by 24.3%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • The gross profit margin for ATHENAHEALTH INC is rather high; currently it is at 65.63%. It has increased from the same quarter the previous year. Despite the strong results of the gross profit margin, ATHN's net profit margin of 4.09% significantly trails the industry average.
  • Net operating cash flow has increased to $44.96 million or 21.18% when compared to the same quarter last year. Despite an increase in cash flow, ATHENAHEALTH INC's cash flow growth rate is still lower than the industry average growth rate of 51.17%.
  • The company, on the basis of change in net income from the same quarter one year ago, has underperformed when compared to that of the S&P 500 and greatly underperformed compared to the Health Care Technology industry average. The net income has significantly decreased by 33.6% when compared to the same quarter one year ago, falling from $13.15 million to $8.73 million.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Health Care Technology industry and the overall market on the basis of return on equity, ATHENAHEALTH INC underperformed against that of the industry average and is significantly less than that of the S&P 500.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet